Enerpac Tool vs Gorman Rupp
EPAC and GRC side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EPAC and GRC compare
Enerpac Tool and Gorman Rupp are about the same size, with market caps of $2.0B and $1.9B.
On earnings, Enerpac Tool is cheaper: it trades at 22.8× trailing earnings, against 25.0× for Gorman Rupp.
Gorman Rupp grew revenue faster over the last twelve months (6.5% versus 5.7% for Enerpac Tool).
Enerpac Tool keeps more of each dollar of sales as profit, with a net margin of 13.8% compared with 10.2% at Gorman Rupp.
Both pay dividends: Enerpac Tool yields 0.10% and Gorman Rupp 1.1%.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EPAC | GRC |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $1.9B |
| Share price | $39.29 | $70.10 |
| Change, 1 year | −2.2% | 57.0% |
| Change, 5 years | 72.3% | 54.6% |
| Beta (5Y) | 0.81 | 0.80 |
| Employees | 2,100 | 1,415 |
| StockData Score | ||
| Total score | 15 | 15 |
| Valuation score | 4 (better) | 2 |
| Growth score | 1 | 3 (better) |
| Performance score | 3 | 5 (better) |
| Health score | 3 | 4 (better) |
| Dividend score | 4 (better) | 1 |
| Valuation | ||
| P/E | 22.8× (better) | 25.0× |
| P/S | 3.1× | 2.6× (better) |
| P/B | – | 4.0× |
| EV/EBITDA | 13.8× (better) | 14.9× |
| P/FCF | 16.9× | 16.8× (better) |
| PEG | 0.82 | – |
| FCF yield | 5.9% | 6.0% (better) |
| Fair value | $43.98 | $67.90 |
| Margin of safety | 10.7% (better) | −3.2% |
| Growth | ||
| Revenue growth (TTM) | 5.7% | 6.5% (better) |
| Revenue growth, 5Y average | 4.3% | 14.4% (better) |
| Net income growth (TTM) | −3.2% | 46.7% (better) |
| EPS growth (TTM) | 1.2% | 46.6% (better) |
| EPS growth, 5Y average | 22.2% | – |
| Profitability | ||
| Gross margin | 49.2% (better) | 32.5% |
| Operating margin | 19.8% (better) | 16.1% |
| Net margin | 13.8% (better) | 10.2% |
| FCF margin | 18.3% (better) | 15.3% |
| Return on equity | – | 17.0% |
| Return on invested capital | – | 13.5% |
| Financial health | ||
| Debt / equity | – | 0.54 |
| Net debt / EBITDA | 0.05 (better) | 1.40 |
| Interest coverage | – | 6.0× |
| Current ratio | 2.73 (better) | 2.70 |
| Altman Z-score | 5.07 (better) | 4.88 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.10% | 1.1% (better) |
| Payout ratio | 2.3% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 0.00% | – |
| Buyback yield | 4.0% (better) | 0.14% |
| Shareholder yield | 4.1% (better) | 1.2% |
| Ownership | ||
| Held by institutions | 99.7% | 66.0% |
| Held by insiders | 1.9% | 14.8% |
| Insider net buying, 12 months | −$400K (better) | −$400K |
| Short interest, % of float | 3.7% | 3.2% |
Go deeper
- EPAC stock overview
- EPAC income statement
- EPAC valuation and score
- GRC stock overview
- GRC income statement
- GRC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.